Annual Retained Earnings
-$2.08 B
-$323.99 M-18.47%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual retained earnings is -$2.08 billion, with the most recent change of -$323.99 million (-18.47%) on December 31, 2023.
- During the last 3 years, RVNC annual retained earnings has fallen by -$952.07 million (-84.53%).
- RVNC annual retained earnings is now -1198.43% below its all-time high of -$160.07 million, reached on December 31, 2011.
Performance
RVNC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.21 B
-$38.12 M-1.76%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly retained earnings is -$2.21 billion, with the most recent change of -$38.12 million (-1.76%) on September 30, 2024.
- Over the past year, RVNC quarterly retained earnings has dropped by -$184.44 million (-9.12%).
- RVNC quarterly retained earnings is now -1087.88% below its all-time high of -$185.80 million, reached on September 30, 2013.
Performance
RVNC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RVNC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -9.1% |
| 3 y3 years | -84.5% | -65.3% |
| 5 y5 years | -203.5% | -176.3% |
RVNC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.7% | at low | -57.9% | at low |
| 5 y | 5-year | -146.2% | at low | -161.4% | at low |
| alltime | all time | -1198.4% | at low | -1087.9% | at low |
Revance Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.21 B(+1.8%) |
| Jun 2024 | - | -$2.17 B(+1.8%) |
| Mar 2024 | - | -$2.13 B(+2.6%) |
| Dec 2023 | -$2.08 B(+18.5%) | -$2.08 B(+2.8%) |
| Sep 2023 | - | -$2.02 B(+7.5%) |
| Jun 2023 | - | -$1.88 B(+3.7%) |
| Mar 2023 | - | -$1.81 B(+3.4%) |
| Dec 2022 | -$1.75 B(+25.5%) | -$1.75 B(+9.1%) |
| Sep 2022 | - | -$1.61 B(+5.6%) |
| Jun 2022 | - | -$1.52 B(+4.2%) |
| Mar 2022 | - | -$1.46 B(+4.6%) |
| Dec 2021 | -$1.40 B(+24.1%) | -$1.40 B(+4.7%) |
| Sep 2021 | - | -$1.33 B(+5.9%) |
| Jun 2021 | - | -$1.26 B(+6.1%) |
| Mar 2021 | - | -$1.19 B(+5.5%) |
| Dec 2020 | -$1.13 B(+33.4%) | -$1.13 B(+7.5%) |
| Sep 2020 | - | -$1.05 B(+8.4%) |
| Jun 2020 | - | -$966.73 M(+6.7%) |
| Mar 2020 | - | -$906.14 M(+7.3%) |
| Dec 2019 | -$844.20 M(+23.3%) | -$844.20 M(+5.7%) |
| Sep 2019 | - | -$798.88 M(+5.5%) |
| Jun 2019 | - | -$757.47 M(+5.2%) |
| Mar 2019 | - | -$720.08 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$684.77 M(+26.3%) | -$684.77 M(+6.3%) |
| Sep 2018 | - | -$644.16 M(+5.4%) |
| Jun 2018 | - | -$611.28 M(+5.9%) |
| Mar 2018 | - | -$577.20 M(+6.5%) |
| Dec 2017 | -$542.17 M(+28.6%) | -$542.17 M(+7.1%) |
| Sep 2017 | - | -$506.26 M(+6.4%) |
| Jun 2017 | - | -$475.61 M(+6.0%) |
| Mar 2017 | - | -$448.74 M(+6.5%) |
| Dec 2016 | -$421.54 M(+26.9%) | -$421.54 M(+6.8%) |
| Sep 2016 | - | -$394.74 M(+4.8%) |
| Jun 2016 | - | -$376.76 M(+7.0%) |
| Mar 2016 | - | -$352.16 M(+6.0%) |
| Dec 2015 | -$332.27 M(+28.4%) | -$332.27 M(+7.1%) |
| Sep 2015 | - | -$310.18 M(+6.6%) |
| Jun 2015 | - | -$291.00 M(+6.1%) |
| Mar 2015 | - | -$274.20 M(+6.0%) |
| Dec 2014 | -$258.80 M(+32.1%) | -$258.80 M(+5.8%) |
| Sep 2014 | - | -$244.59 M(+6.1%) |
| Jun 2014 | - | -$230.61 M(+6.1%) |
| Mar 2014 | - | -$217.31 M(+10.9%) |
| Dec 2013 | -$195.88 M(-10.3%) | -$195.88 M(+5.4%) |
| Sep 2013 | - | -$185.80 M(-14.9%) |
| Dec 2012 | -$218.33 M(+36.4%) | -$218.33 M |
| Dec 2011 | -$160.07 M | - |
FAQ
- What is Revance Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Revance Therapeutics?
- What is Revance Therapeutics annual retained earnings year-on-year change?
- What is Revance Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Revance Therapeutics?
- What is Revance Therapeutics quarterly retained earnings year-on-year change?
What is Revance Therapeutics annual retained earnings?
The current annual retained earnings of RVNC is -$2.08 B
What is the all time high annual retained earnings for Revance Therapeutics?
Revance Therapeutics all-time high annual retained earnings is -$160.07 M
What is Revance Therapeutics annual retained earnings year-on-year change?
Over the past year, RVNC annual retained earnings has changed by -$323.99 M (-18.47%)
What is Revance Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RVNC is -$2.21 B
What is the all time high quarterly retained earnings for Revance Therapeutics?
Revance Therapeutics all-time high quarterly retained earnings is -$185.80 M
What is Revance Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RVNC quarterly retained earnings has changed by -$184.44 M (-9.12%)